Epigenetic therapy reprograms hereditary disease

Blood

Volumn 124, Issue 1, 2014, Pages 7-8

  Bautista, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HISTONE DEACETYLASE INHIBITOR;

ENZYME ACTIVITY; EPIGENETICS; ERYTHROID PRECURSOR CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEREDITARY HEMOLYTIC ANEMIA; HOUSEKEEPING GENE; HUMAN; MODIFIER GENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION INITIATION; UPREGULATION; BIOSYNTHESIS; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY;

EPIGENESIS, GENETIC; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HISTONE DEACETYLASE INHIBITORS; HUMANS; TRANSCRIPTION, GENETIC;

EID: 84903989795     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-05-575423     Document Type: Review

References (10)

1. Makarona K, Caputo VS, Costa JR, et al. Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells. Blood. 2014;124(1):134-141.
2. Roos D, van Zwieten R, Wijnen JT, et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood. 1999;94(9):2955-2962. (Pubitemid 29512698)
3. Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007; 21(5):267-283. (Pubitemid 47212602)
4. Longo L, Vanegas OC, Patel M, et al. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J. 2002;21(16): 4229-4239.
5. McDonagh EM, Thorn CF, Bautista JM, Youngster I, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for G6PD. Pharmacogenet Genomics. 2012;22(3):219-228.
6. Kondrashin A, Baranova AM, Ashley EA, Recht J, White NJ, Sergiev VP. Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malar J. 2014;13(1):51.
7. Kwak H, Fuda NJ, Core LJ, Lis JT. Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science. 2013;339(6122):950-953.
8. Wang Z, Zang C, Cui K, et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell. 2009; 138(5):1019-1031.
9. Almeida AM, Murakami Y, Baker A, et al. Targeted therapy for inherited GPI deficiency. N Engl J Med. 2007; 356(16):1641-1647. (Pubitemid 46631673)
10. Atweh GF, Sutton M, Nassif I, et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 1999;93(6):1790-1797. (Pubitemid 29128478)